Huateng Pharma is a leading and professional manufacturer which can provide fine chemicals, PEG derivatives, biochemical reagents, pharmaceutical APIs & intermediates, Vitamin D Derivatives for our customers, it offers CAS NO.913611-97-9 for your requirements of R&D, evaluation, pilots and commercial along with supportive technical package required for evaluation.

Application: Brexpiprazole is a drug candidate useful in treatment and prevention of mental disorders including CNS disorders. The drug received FDA approval on July 13, 2015 for the treatment of schizophrenia, and as an adjunctive treatment for depression.

Find More Brexpiprazole Intermediates>>>